Join
Live feed
·
PRReleasevia Quantisnow
Matinas Biopharma Holdings Inc. logo

Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation

ByQuantisnow·Wall Street's wire, on your screen.
MTNB· Matinas Biopharma Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MTNB (Matinas Biopharma Holdings Inc.) and more on Quantisnow.